Cholangiocarcinoma (CCA) is a highly lethal adenocarcinoma of the hepatobiliary system,
which can be classified as intrahepatic, perihilar and distal. Each anatomic subtype has …

Cholangiocarcinoma (CCA) includes a cluster of highly heterogeneous biliary malignant
tumours that can arise at any point of the biliary tree. Their incidence is increasing globally …

The incidence of intrahepatic cholangiocarcinoma (iCCA) is increasing worldwide. Although
several advances have been made in the past decades to better understand this complex …

Surgical resection is the only potentially curative treatment for patients with
cholangiocarcinoma. For both perihilar cholangiocarcinoma (pCCA) and intrahepatic …

Cholangiocarcinoma (CCA) is a heterogeneous group of tumours, derived from cells of the
biliary tree, which represent the second most frequent primary liver tumour. According to the …

Cholangiocarcinoma (CCA) is a heterogeneous group of malignancies with features of
biliary tract differentiation. CCA is the second most common primary liver tumour and the …

Background: Primary liver cancer is a leading cause of cancer deaths worldwide. Global
burden varies, reflecting geographical distribution of viral hepatitis. Our objective was to …

Primary liver cancer—including hepatocellular carcinoma (HCC) and intrahepatic
cholangiocarcinoma (ICC)—incidence is increasing and is an important source of cancer …

Background and Aim Genetic alterations in intrahepatic cholangiocarcinoma (iCCA) are
increasingly well characterized, but their impact on outcome and prognosis remains …

Objectives: To determine the prognostic implication of the number and station of LNM, and
the minimal number of LNs needed for evaluation to accurately stage patients with …